Annual report pursuant to Section 13 and 15(d)

Revenue Information (Tables)

v3.20.1
Revenue Information (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Schedule of Revenue by Product Lines

Revenue by product lines was as follows:

 

    Years Ended  
    December 31,  
Product Line   2019     2018  
MicroParticle Catalyzed Biosensor (“MPC”)   $ 126,150     $ 123,941  
Particle ImmunoFiltration Assay (“PIFA”)     1,327,752       1,422,361  
Rapid Enzymatic Assay (“REA”)     85,000       68,750  
Other     38,131       50,518  
Total Revenue   $ 1,577,033     $ 1,665,570  

Schedule of Revenue by Geographic Area Determined Based On Location of Customers

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Years Ended  
    December 31,  
Geographic Region   2019     2018  
United States   $ 1,559,533     $ 1,576,765  
Rest of World     17,500       88,805  
Total Revenue   $ 1,577,033     $ 1,665,570